Navigation Links
Martek Biosciences Inducted into Small Business Innovation Research (SBIR) Hall of Fame
Date:2/17/2011

COLUMBIA, Md., Feb. 17, 2011 /PRNewswire/ -- Martek Biosciences Corporation (Nasdaq: MATK), a leader in the innovation, development, production and sales of high-value products from microbial sources that promote health and wellness through nutrition, announced today that it has been inducted into the inaugural Small Business Innovation Research (SBIR) Hall of Fame, a program under the U.S. Small Business Administration. Martek Biosciences was recognized for its success in research, innovation and commercialization within the SBIR program. Martek was honored at the national inductee ceremony held on February 15, 2011 in Washington, DC, followed by a White House reception.  

"We are honored to be one of only eight companies inducted into the first-ever SBIR Hall of Fame," said Steve Dubin, CEO of Martek Biosciences. "Our success over the past 26 years has been realized in part from the funding and support we received through the SBIR program during our early start-up stage. What started with a few visionary and passionate scientists is now a company with more than 600 employees, revenues of more than $450 million and a thriving and robust technology pipeline."

SBIR is a highly-competitive program that encourages small businesses to explore their technological potential and provides the incentive to profit from its commercialization. By including qualified small businesses in the nation's R&D arena, high-tech innovation is stimulated and the United States gains entrepreneurial spirit and grows jobs as it meets its specific research and development needs.

All SBIR Hall of Fame award winners were selected by the SBA based on the recommendations of a panel of judges. Inductees were evaluated based on a company's technical innovation, business impact, broader social and economic benefit, degree of impact and longevity.

About MartekMartek Biosciences Corporation (Nasdaq: MATK) is a leader in the innovation, development, production and sales of high-value products from microbial sources that promote health and wellness through nutrition.  The company is the world's leading provider of algal DHA omega-3 with its flagship product, life'sDHA™, a sustainable and vegetarian source of algal DHA omega-3 important for brain, heart and eye health throughout life, for use in foods, beverages, infant formula, and supplements. The company also produces life'sARA™ (arachidonic acid), an omega-6 fatty acid, for use in infant formula and growing up milks. Additionally, Martek's subsidiary, Amerifit Brands, develops, markets and distributes branded consumer health and wellness products in major mass, club, drug, grocery and specialty stores and holds leading brand positions in all of its key product categories. For more information on Martek Biosciences, visit http://www.martek.com/. For information about life'sDHA or life'sARA products, visit www.lifesdha.com/ or www.algaldha.com. For more information about Amerifit Brands, visit www.amerifit.com.

Sections of this release contain forward-looking statements. These statements are based upon numerous assumptions which Martek cannot control and involve risks and uncertainties that could cause actual results to differ. These statements should be understood in light of the risk factors set forth in the company's filings with the Securities and Exchange Commission, including, but not limited to, the company's Form 10-K for the fiscal year ended October 31, 2010 and other filed reports on Form 10-K, Form 10-K/A, Form 10-Q and Form 8-K.Contact:Cassie France-KellyPublic Relations (443) 542-2116media@martek.comKyle StultsInvestor Relations(410) 740-0081investors@martek.com
'/>"/>

SOURCE Martek Biosciences Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Martek Is Second Mtech Company Sold for More Than $1 Billion in Three Years
2. Martek Announces Fourth Quarter and FY 2010 Financial Results
3. Martek to Present at Upcoming Citi Small / Mid Cap Conference
4. Martek to Present at Upcoming UBS Conference
5. Martek Announces Third Quarter FY 2010 Financial Results
6. Martek Announces Fourth Quarter and FY 2009 Financial Results
7. Martek Signs Sole-Source Supply Agreement with Fonterra
8. Martek to Announce Fourth Quarter and Fiscal Year 2009 Results
9. Martek Announces Addition to Its Board of Directors
10. Martek to Present at Two Upcoming Investor Conferences
11. Martek Announces Settlement of Patent Dispute with Capsugel France
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... Despite the volatility that continues to ... Today,s pre-market research on ActiveWallSt.com directs the investor community,s focus ... RDUS ), Cerus Corp. (NASDAQ: CERS ), ... Prime Therapeutics Inc. (NASDAQ: FPRX ). Register with ... http://www.activewallst.com/ On Wednesday, shares in ...
(Date:5/25/2016)... Bangkok, Thailand (PRWEB) , ... May 25, 2016 ... ... the participation of a Thai delegation at BIO 2016 in San Francisco. Located ... private sector will be available to answer questions and discuss the Thai biotechnology ...
(Date:5/25/2016)... (PRWEB) , ... May 25, 2016 , ... WEDI, the ... information exchange, today announced that Charles W. Stellar has been named by the WEDI ... CEO since January 2016. As an executive leader with more than 35 years of ...
(Date:5/24/2016)... ... May 24, 2016 , ... Last week, Callan Capital, an integrated wealth ... held The Future of San Diego Life Science event at the Estancia La Jolla ... attended the event with speakers Dr. Rich Heyman, former CEO of Aragon and Seragon, ...
Breaking Biology Technology:
(Date:5/12/2016)... 12, 2016 WearablesResearch.com , a brand ... overview results from the Q1 wave of its quarterly ... was consumers, receptivity to a program where they would ... health insurance company. "We were surprised to ... Michael LaColla , CEO of Troubadour Research, "primarily ...
(Date:5/3/2016)... VILNIUS, Lithuania , May 3, 2016 /PRNewswire/ ... today released the MegaMatcher Automated Biometric Identification ... deployment of large-scale multi-biometric projects. MegaMatcher ABIS can ... and accuracy using any combination of fingerprint, face ... of MegaMatcher SDK and MegaMatcher ...
(Date:4/28/2016)... , April 28, 2016 First quarter ... (139.9), up 966% compared with the first quarter of 2015 ... totaled SEK 589.1 M (loss: 18.8) and the operating margin was ... (loss: 0.32) Cash flow from operations was SEK 249.9 ... 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. The ...
Breaking Biology News(10 mins):